Strs Ohio Halozyme Therapeutics, Inc. Transaction History

Strs Ohio

$25.5 Billion
Q3 2024

A detailed history of Strs Ohio transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Strs Ohio holds 31,700 shares of HALO stock, worth $1.51 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

31,700

Previous 31,700 -0.0%

Holding current value

$1.51 Million

Previous $1.66 Million 9.28%

% of portfolio

0.01%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	SELL	$37.81 - $52.4 $90,744 - $125,760	-2,400 Reduced 7.04%	31,700 $1.66 Million
Q1 2024 May 13, 2024	SELL	$33.68 - $41.95 $138,088 - $171,995	-4,100 Reduced 10.73%	34,100 $1.39 Million
Q4 2023 Jan 30, 2024	SELL	$33.32 - $42.1 $59,976 - $75,780	-1,800 Reduced 4.5%	38,200 $1.41 Million
Q3 2023 Oct 26, 2023	SELL	$36.46 - $44.03 $80,212 - $96,866	-2,200 Reduced 5.21%	40,000 $1.53 Million
Q2 2023 Jul 31, 2023	BUY	$30.28 - $38.74 $363,360 - $464,880	12,000 Added 39.74%	42,200 $1.52 Million
Q1 2023 Aug 02, 2023	SELL	$32.86 - $55.7 $394,320 - $668,400	-12,000 Reduced 28.44%	30,200 $1.15 Million
Q1 2023 Apr 27, 2023	BUY	$32.86 - $55.7 $121,582 - $206,090	3,700 Added 13.96%	30,200 $1.15 Million
Q4 2022 Jan 26, 2023	SELL	$40.06 - $59.44 $701,050 - $1.04 Million	-17,500 Reduced 39.77%	26,500 $1.51 Million
Q3 2022 Oct 27, 2022	BUY	$38.53 - $51.78 $670,422 - $900,972	17,400 Added 65.41%	44,000 $1.74 Million
Q2 2022 Jul 25, 2022	BUY	$37.35 - $48.3 $153,135 - $198,030	4,100 Added 18.22%	26,600 $1.17 Million
Q1 2022 Apr 21, 2022	SELL	$31.97 - $41.06 $923,933 - $1.19 Million	-28,900 Reduced 56.23%	22,500 $897,000
Q4 2021 Jan 24, 2022	BUY	$31.82 - $40.75 $79,550 - $101,875	2,500 Added 5.11%	51,400 $2.07 Million
Q2 2021 Jul 26, 2021	BUY	$38.84 - $51.31 $1.22 Million - $1.62 Million	31,500 Added 181.03%	48,900 $2.22 Million
Q1 2021 Apr 23, 2021	SELL	$39.51 - $51.45 $31,608 - $41,160	-800 Reduced 4.4%	17,400 $725,000
Q4 2020 Jan 25, 2021	BUY	$25.81 - $43.62 $43,877 - $74,154	1,700 Added 10.3%	18,200 $777,000
Q3 2020 Dec 14, 2020	SELL	$25.74 - $29.63 $15,443 - $17,778	-600 Reduced 3.51%	16,500 $433,000
Q2 2020 Jul 23, 2020	SELL	$16.25 - $26.81 $152,750 - $252,014	-9,400 Reduced 35.47%	17,100 $458,000
Q1 2020 Apr 23, 2020	SELL	$13.9 - $21.83 $547,660 - $860,101	-39,400 Reduced 59.79%	26,500 $476,000
Q4 2019 Jan 24, 2020	SELL	$14.93 - $19.53 $62,706 - $82,026	-4,200 Reduced 5.99%	65,900 $1.17 Million
Q2 2019 Jul 25, 2019	BUY	$14.75 - $17.26 $50,150 - $58,684	3,400 Added 5.1%	70,100 $1.2 Million
Q4 2018 Jan 23, 2019	BUY	$13.33 - $18.66 $14,663 - $20,526	1,100 Added 1.68%	66,700 $975,000
Q2 2018 Aug 06, 2018	BUY	$16.87 - $20.3 $1.03 Million - $1.24 Million	61,300 Added 1425.58%	65,600 $1.11 Million
Q1 2018 Apr 20, 2018	BUY	$17.06 - $21.2 $8,530 - $10,600	500 Added 13.16%	4,300 $84,000
Q4 2017 Jan 23, 2018	BUY	$16.75 - $20.8 $63,650 - $79,040	3,800	3,800 $76,000

Others Institutions Holding HALO

# of Institutions

543

Shares Held

125M

Call Options Held

294K

Put Options Held

180K

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.62B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.

Account